-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

601.O1.6 601. Chromosomal Rearrangements and DNA Repair: Genomic Instability and Clonal Evolution In Hematopoietic Malignancy

Chromosomal Rearrangements and DNA Repair Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 7:30 AM-9:00 AM
W312, Level 3 (Orange County Convention Center)
Moderators:
and Markus Muschen, MD, PhD, University of California San Francisco

Disclosures:
No relevant conflicts of interest to declare.
7:30 AM

Lili Chen, PhD1, Yuqing Sun1*, Jingya Wang, PhD1*, Hui Jiang, PhD2* and Andrew G. Muntean, PhD1

1Department of Pathology, University of Michigan, Ann Arbor, MI
2Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI

7:45 AM

Mara Compagno1*, Wang Qi1*, Chiara Pighi1*, Feilong Meng2*, Taek-Chin Cheong1*, Teresa Poggio3*, Fernanda Langellotto1*, Claudia Voena3*, Monica Gostissa2*, Frederick Alt2* and Roberto Chiarle1,3

1Department of Pathology, Boston Children's Hospital, Boston, MA
2Department of Genetics, Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA
3Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy

8:00 AM

Jana Reimer1*, Sabine Knoess1*, Maurice Labuhn1*, Emmanuelle Marie Charpentier, PhD2,3*, Jan-Henning Klusmann, MD1 and Dirk Heckl, PhD1*

1Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
2Regulation in Infection Biology (REGI), Helmholtz Centre for Infection Research / Hannover Medical School,, Hannover, Germany
3The Laboratory for Molecular Infection Medicine Sweden, Umea, Sweden

8:15 AM

Lars Klemm, BSc, MSc1*, Srividya Swaminathan, DPhil2*, Elli Papaemmanuil, PhD3*, Anthony M Ford4, Mel Greaves5, Rafael Casellas6*, David Schatz7*, Michael R. Lieber, MD-PhD8* and Markus Muschen, MD, PhD9

1University of California San Francisco, San Francisco, CA
2University of California, San Francisco, San Francisco, CA
3Memorial Sloan Kettering Cancer Center, New York
4Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
5Haematology-Oncology, Institute of Cancer Research, Sutton, United Kingdom
6NIAMS, National Institutes of Health, Bethesda, MD
7Yale University School of Medicine, New Haven, CT
8University of Southern California, Los Angeles, CA
9Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA

8:30 AM

Ceri Oldreive1*, Nick Davies, PhD1*, Anna Skowronska, PhD1,2*, Marwan Kwok, MB ChB, MRCP1*, Guy Pratt, MD PhD1, Paul Moss1, Michael John Griffiths, BSc2*, Samuel Clokie2*, A. Malcolm R Taylor1* and Tatjana Stankovic1

1School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom
2West Midlands Regional Genetics Laboratory, Birmingham, United Kingdom

8:45 AM

Timothy Michael Chlon, PhD1, Susanne I Wells, PhD1*, Sonya Ruiz-Torres1*, Matthew Kuhar2* and James M Wells, PhD1*

1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital, Cincinnati, OH
2Developmental Biology, Cincinnati Children's Hospital, Cincinnati, OH

*signifies non-member of ASH